Daiichi Sankyo is facing a new Benicar (Olmesartan) lawsuit, from a patient who had suffered a number of complications from the hypertension medication.

Like many others who had used the drug, the patient had been prescribed Benicar to treat high blood pressure and prevent heart disease.

However the patient had experienced Benicar and kidney failure problems soon after starting the medication, resulting in long term medical conditions.

Mississippi plaintiff Sidney T. began taking Benicar on April 07, 2003, and had followed all prescription instructions.

Sidney had also followed additional physician advice, and did not use the drug outside of its intended purpose. Even though Sidney had followed these precautions, the experience of Benicar and kidney failure problems occurred.

The Benicar complications listed in Sidney’s lawsuit include: chronic diarrhea, sprue like enteropathy, malabsorption, malnutrition, villous atrophy, and kidney failure.

Long term complications like villous atrophy, a gastrointestinal condition, will cause Sidney to have permanent difficulty in absorbing vital nutrients from food.

Kidney failure is another long term health condition that will infringe on Sidney’s life, but can be potentially fatal if not treated.

Sidney is filing legal action against Daiichi Sankyo for failing to warn her against the long term Benicar and kidney failure complications.

Overview of Benicar and Kidney Failure Complications

Approximately 67 million Americans suffer from high blood pressure, to which they manage through medications like Benicar. These medications work by improving the circulation, and can ideally improve the improve the patient’s chances of greater longevity.

Even Benicar can be very beneficial in their purposes, many patients have been reported long term complications like villous atrophy and kidney failure. For years after Benicar was released, numerous patients had reported long term complications soon after using the drug.

It was not until the FDA issued a public safety warning in July 2013, warning patients against the gastrointestinal side effects of this medication. The agency had issued this warning after reviewing a study conducted by the Mayo Clinic in 2012, which showed Benicar patients were more likely to develop villous atrophy and other gastrointestinal damage.

Previously it was thought that Benicar patients who developed diarrhea or sprue like enteropathy had Celiac disease, but the Mayo Clinic subjects had tested negative.

Due to the nature of these long term injuries, Benicar and kidney failure have become a potential alarming correlation for patients and medical experts alike.

Sidney states that if the Benicar and kidney failure side effects had been previously disclosed, she would not have taken the medication. Sidney is one of numerous patients had suffered these Benicar side effects, resulting in the formation of the multidistrict litigation (MDL).

The Benicar Lawsuit is Case No. 1:16-cv-04864, in the U.S. District Court of New Jersey, Camden Vicinage.